BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

9.11
Delayed Data
As of May 20
 +0.08 / +0.89%
Today’s Change
7.61
Today|||52-Week Range
19.99
-34.22%
Year-to-Date

Today’s Trading

Previous close9.03
Today’s open9.08
Day’s range8.67 - 9.20
Volume220,528
Average volume (3 months)4,927,466
Market cap$1.6B
Data as of 4:04pm ET, 05/20/2022

Growth & Valuation

Earnings growth (last year)+5.98%
Earnings growth (this year)-25.86%
Earnings growth (next 5 years)+4.47%
Revenue growth (last year)+782.38%
P/E ratioNM
Price/Sales15.78
Price/Book--

Competitors

----
AUPHAurinia Pharmaceutic...+0.41+3.52%
----
EBSEmergent BioSolution...+3.64+11.49%
Data as of 4:04pm ET, 05/20/2022

Financials

Next reporting dateAugust 9, 2022
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$157.2M
Annual profit (last year)-$184.1M
Net profit margin-117.11%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Durham, North Carolina

Forecasts